Anton Leighton

966 total citations
10 papers, 758 citations indexed

About

Anton Leighton is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Anton Leighton has authored 10 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Anton Leighton's work include Antimicrobial Resistance in Staphylococcus (4 papers), Sepsis Diagnosis and Treatment (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Anton Leighton is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (4 papers), Sepsis Diagnosis and Treatment (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Anton Leighton collaborates with scholars based in United States, Switzerland and India. Anton Leighton's co-authors include Thomas Butler, Alice B. Gottlieb, Marcus Dörr, Kathleen C. M. Campbell, Ellen Kelly, Daniela Jabés, Edward J. Mroszczak, Giorgio Mosconi, Konrad Reinhart and Edward Abraham and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

Anton Leighton

10 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anton Leighton United States 9 292 197 152 147 96 10 758
S M Opal United States 9 332 1.1× 115 0.6× 292 1.9× 185 1.3× 60 0.6× 11 912
Julius J. Schmidt Germany 19 338 1.2× 248 1.3× 149 1.0× 100 0.7× 69 0.7× 55 946
Sanna Gudmundsson Sweden 15 316 1.1× 96 0.5× 119 0.8× 189 1.3× 29 0.3× 31 910
J. Gérain Belgium 14 354 1.2× 76 0.4× 412 2.7× 203 1.4× 37 0.4× 31 1.1k
Maria Mouktaroudi Greece 15 366 1.3× 202 1.0× 332 2.2× 191 1.3× 47 0.5× 30 955
Sebastiaan Weijer Netherlands 16 446 1.5× 141 0.7× 444 2.9× 271 1.8× 125 1.3× 23 1.1k
Franz Ratzinger Austria 14 170 0.6× 73 0.4× 148 1.0× 71 0.5× 54 0.6× 41 583
Daanish Hoda United States 13 152 0.5× 340 1.7× 72 0.5× 133 0.9× 120 1.3× 43 725
Fabrice Uhel France 20 361 1.2× 178 0.9× 550 3.6× 273 1.9× 37 0.4× 46 1.3k
Carl Johan Treutiger Sweden 13 285 1.0× 115 0.6× 564 3.7× 192 1.3× 33 0.3× 22 1.2k

Countries citing papers authored by Anton Leighton

Since Specialization
Citations

This map shows the geographic impact of Anton Leighton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Leighton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Leighton more than expected).

Fields of papers citing papers by Anton Leighton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Leighton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Leighton. The network helps show where Anton Leighton may publish in the future.

Co-authorship network of co-authors of Anton Leighton

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Leighton. A scholar is included among the top collaborators of Anton Leighton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Leighton. Anton Leighton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Conway, Janet D., Ronald E. Delanois, Michael A. Mont, et al.. (2024). Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip. Antimicrobial Agents and Chemotherapy. 68(8). e0065524–e0065524. 9 indexed citations
2.
Xiong, Yan Q., Angeles Estellés, Liang Li, et al.. (2017). A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections. Antimicrobial Agents and Chemotherapy. 61(10). 47 indexed citations
3.
Estellés, Angeles, Anne-Kathrin Woischnig, Keyi Liu, et al.. (2016). A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model. Antimicrobial Agents and Chemotherapy. 60(4). 2292–2301. 63 indexed citations
4.
Leighton, Anton. (2007). Safety of Iclaprim in Complicated Skin and Skin Structure Infections: ASSIST-1 Results. 3 indexed citations
5.
Leighton, Anton, Alice B. Gottlieb, Marcus Dörr, et al.. (2004). Tolerability, Pharmacokinetics, and Serum Bactericidal Activity of Intravenous Dalbavancin in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 48(3). 940–945. 158 indexed citations
6.
Campbell, Kathleen C. M., et al.. (2003). Audiologic Monitoring for Potential Ototoxicity in a Phase I Clinical Trial of a New Glycopeptide Antibiotic. Journal of the American Academy of Audiology. 14(3). 157–168. 28 indexed citations
7.
Dowell, James A., Alice B. Gottlieb, Anton Leighton, et al.. (2002). The pharmacokinetics and renal excretion of dalbavancin in healthy subjects. 42. 18. 9 indexed citations
8.
Abraham, Edward, Konrad Reinhart, Petr Svoboda, et al.. (2001). Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Critical Care Medicine. 29(11). 2081–2089. 193 indexed citations
9.
10.
Pittet, Didier, Stephan Harbarth, Peter M. Suter, et al.. (1999). Impact of Immunomodulating Therapy on Morbidity in Patients with Severe Sepsis. American Journal of Respiratory and Critical Care Medicine. 160(3). 852–857. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S M Opal Breakdown of academic impact, for papers by Julius J. Schmidt Breakdown of academic impact, for papers by Sanna Gudmundsson Breakdown of academic impact, for papers by J. Gérain Breakdown of academic impact, for papers by Maria Mouktaroudi Breakdown of academic impact, for papers by Sebastiaan Weijer Breakdown of academic impact, for papers by Franz Ratzinger Breakdown of academic impact, for papers by Daanish Hoda Breakdown of academic impact, for papers by Fabrice Uhel Breakdown of academic impact, for papers by Carl Johan Treutiger
Rankless by CCL
2026